These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 33634692)

  • 1. Practical Remdesivir Synthesis through One-Pot Organocatalyzed Asymmetric (
    Gannedi V; Villuri BK; Reddy SN; Ku CC; Wong CH; Hung SC
    J Org Chem; 2021 Apr; 86(7):4977-4985. PubMed ID: 33634692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catalytic Asymmetric Synthesis of the anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Yuan Q; Li P; Chen J; Zou Y; Wu Z; Zhang W
    Angew Chem Int Ed Engl; 2020 Nov; 59(47):20814-20819. PubMed ID: 32870563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Chemoenzymatic Synthesis of the (
    Bigley AN; Narindoshvili T; Raushel FM
    Biochemistry; 2020 Aug; 59(33):3038-3043. PubMed ID: 32786401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weinreb Amide Approach to the Practical Synthesis of a Key Remdesivir Intermediate.
    Xie Y; Hu T; Zhang Y; Wei D; Zheng W; Zhu F; Tian G; Aisa HA; Shen J
    J Org Chem; 2021 Apr; 86(7):5065-5072. PubMed ID: 33733767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemical Synthesis of the Anti-COVID-19 Drug Remdesivir.
    Wang M; Zhang L; Huo X; Zhang Z; Zhang W
    Curr Protoc; 2021 Dec; 1(12):e303. PubMed ID: 34878730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Direct and Catalytic C-Glycosylation of Arenes: Expeditious Synthesis of the Remdesivir Nucleoside.
    Obradors C; Mitschke B; Aukland MH; Leutzsch M; Grossmann O; Brunen S; Schwengers SA; List B
    Angew Chem Int Ed Engl; 2022 Mar; 61(11):e202114619. PubMed ID: 34856043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the Inhibition Mechanism of RNA-Dependent RNA Polymerase (RdRp) of SARS-CoV-2 by Remdesivir and Nucleotide Analogues: A Molecular Dynamics Simulation Study.
    Wakchaure PD; Ghosh S; Ganguly B
    J Phys Chem B; 2020 Nov; 124(47):10641-10652. PubMed ID: 33190493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developing an Ethics Framework for Allocating Remdesivir in the COVID-19 Pandemic.
    Lim S; DeBruin DA; Leider JP; Sederstrom N; Lynfield R; Baker JV; Kline S; Kesler S; Rizza S; Wu J; Sharp RR; Wolf SM
    Mayo Clin Proc; 2020 Sep; 95(9):1946-1954. PubMed ID: 32861338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Remdesivir for Treatment of COVID-19: Combination of Pulmonary and IV Administration May Offer Aditional Benefit.
    Sun D
    AAPS J; 2020 May; 22(4):77. PubMed ID: 32458279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remdesivir-COVID-19: drug interactions in dentistry.
    Gómez-Moreno G
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9739-9743. PubMed ID: 33015819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dozens of coronavirus drugs are in development - what happens next?
    Ledford H
    Nature; 2020 May; 581(7808):247-248. PubMed ID: 32409766
    [No Abstract]   [Full Text] [Related]  

  • 12. Remdesivir in Treatment of COVID-19: A Systematic Benefit-Risk Assessment.
    Davies M; Osborne V; Lane S; Roy D; Dhanda S; Evans A; Shakir S
    Drug Saf; 2020 Jul; 43(7):645-656. PubMed ID: 32468196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Remdesivir for patients with severe COVID-19].
    Augustin M; Hallek M; Nitschmann S
    Internist (Berl); 2020 Jun; 61(6):644-645. PubMed ID: 32333086
    [No Abstract]   [Full Text] [Related]  

  • 14. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantification of plasma remdesivir and its metabolite GS-441524 using liquid chromatography coupled to tandem mass spectrometry. Application to a Covid-19 treated patient.
    Alvarez JC; Moine P; Etting I; Annane D; Larabi IA
    Clin Chem Lab Med; 2020 Aug; 58(9):1461-1468. PubMed ID: 32573468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency.
    Gordon CJ; Tchesnokov EP; Woolner E; Perry JK; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 May; 295(20):6785-6797. PubMed ID: 32284326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus.
    Gordon CJ; Tchesnokov EP; Feng JY; Porter DP; Götte M
    J Biol Chem; 2020 Apr; 295(15):4773-4779. PubMed ID: 32094225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reply to Yan and Muller, "Single-Cell RNA Sequencing Supports Preferential Bioactivation of Remdesivir in the Liver".
    Murakami E; Bilello J; Li R; Li L; Porter D; Humeniuk R; Mackman R; Cihlar T; Osinusi A; Feng J
    Antimicrob Agents Chemother; 2021 Sep; 65(10):e0139421. PubMed ID: 34370585
    [No Abstract]   [Full Text] [Related]  

  • 20. Practical and Highly Efficient Synthesis of Remdesivir from GS-441524.
    Hu T; Zhu F; Xiang L; Shen J; Xie Y; Aisa HA
    ACS Omega; 2022 Aug; 7(31):27516-27522. PubMed ID: 35967033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.